Cresset Donates to Novartis’ TExts to Sub-Saharan Africa Project
News Sep 30, 2014
Cresset has provided a donation to Novartis Institutes for Biomedical Research’s (NIBR) in support of their TExts to Sub-Saharan Africa (TESSA) project.
Dr. Lewis Whitehead, computational medicinal chemist at NIBR says, “Textbooks have proved invaluable to students over the years. Now that many developed countries are turning to online learning resources, NIBR’s TESSA project is using this opportunity to send the redundant textbooks to Sub-Saharan Africa. We welcome the donation from Cresset to help us in this project.”
“Cresset is delighted to support NIBR’s project,” says Dr. David Bardsley, Cresset’s Commercial Director. “As a company, Cresset is committed to creating software that advances the understanding of the biological effects of molecular changes. We wholeheartedly support NIBR’s project to increase scientific knowledge in sub-Saharan Africa.”
Elpis BioMed Closes Funding Round to Commercialise Novel Technology Platform for Generating Human Cell TypesNews
New Cambridge spin-out company commercialises disruptive technology that enables rapid generation of pure and consistent batches of human cell types. Geographically diversified, top-tier investor team includes key industry leaders to support early company development.READ MORE